Literature DB >> 13799736

Clinical trial of high dosage vitamin E in human muscular dystrophy.

G M BERNESKE, A R BUTSON, E N GAULD, D LEVY.   

Abstract

Entities:  

Keywords:  MUSCULAR DYSTROPHY/therapy; VITAMIN E/therapy

Mesh:

Substances:

Year:  1960        PMID: 13799736      PMCID: PMC1937822     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Metabolic studies in atherosclerosis. I. Metabolic pathway of C14 labelled alpha-tocopherol.

Authors:  J STERNBERG; E PASCOE-DAWSON
Journal:  Can Med Assoc J       Date:  1959-02-15       Impact factor: 8.262

2.  Avitaminosis E in cystic fibrosis of the pancreas: a morphologic study of gastrointestinal and striated muscle.

Authors:  W A BLANC; J D REID; D H ANDERSEN
Journal:  Pediatrics       Date:  1958-09       Impact factor: 7.124

3.  Prevention and cure of enzootic muscular dystrophy in beef cattle.

Authors:  K L BLAXTER; G A SHARMAN
Journal:  Nature       Date:  1953-11-28       Impact factor: 49.962

4.  THE DEFECT IN UTILIZATION OF TOCOPHEROL IN PROGRESSIVE MUSCULAR DYSTROPHY.

Authors:  A T Milhorat; W E Bartels
Journal:  Science       Date:  1945-01-26       Impact factor: 47.728

  4 in total
  4 in total

1.  A trial of therapy by nucleosides and nucleotides in muscular dystrophy.

Authors:  W H THOMSON; K E GUEST
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-04       Impact factor: 10.154

2.  Physiological and therapeutic role of vitamin E in humans: an update.

Authors:  K D Moudgil; B S Narang
Journal:  Indian J Pediatr       Date:  1984 Nov-Dec       Impact factor: 1.967

Review 3.  Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy.

Authors:  Jong-Hee Kim; Hyo-Bum Kwak; LaDora V Thompson; John M Lawler
Journal:  J Muscle Res Cell Motil       Date:  2012-10-28       Impact factor: 2.698

4.  Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future.

Authors:  Agnieszka Łoboda; Józef Dulak
Journal:  Pharmacol Rep       Date:  2020-07-20       Impact factor: 3.024

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.